U.S. market Closed. Opens in 5 hours 6 minutes

CAPR | Capricor Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue25.18M2.55M244.90K310.25K1.01M1.67M2.67M4.00M5.52M4.79M503.23K195.50K1.35MN/AN/AN/A101.40KN/AN/AN/A2.18K11.48KN/AN/AN/A
Cost of Revenue1.07M694.87K245.70K8.46M5.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit24.11M1.85M-799.00-8.15M-4.14M1.67MN/AN/A5.52M4.79M503.23K195.50K1.35MN/AN/AN/A101.40KN/AN/AN/A2.18K11.48KN/AN/AN/A
Operating Expenses48.19M32.25M21.18M14.00M8.74M17.00M15.53M20.98M18.13M10.80M7.41M2.64M6.25M6.29M7.88M13.40M9.60M60.40K18.86K18.98K18.34K29.26K22.30K36.52K200.00
Selling, General & Admin12.37M10.43M7.61M5.54M3.60M4.93M4.76M4.93M4.37M3.02M2.21M1.61M2.12M2.21M3.42M3.92M4.48M60.40K18.86K18.98K18.34K29.26K22.22K10.43KN/A
Research & Development35.82M21.82M13.57M8.46M5.14M12.07M10.77M16.04M13.76M7.79M5.20M1.02M4.14M4.08M4.47M9.48M5.12MN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses67.66K190.58K548.21KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A83.0026.09K200.00
Operating Income-24.08M-29.70M-20.94M-13.69M-7.73M-15.33M-12.86M-16.98M-12.61M-6.02M-6.90M-2.44M-4.90M-6.29M-7.88M-13.40M-9.50M-60.40K-18.86K-18.98K-16.16K-17.78K-22.30K-36.52K-200.00
Other Expenses / Income1.79M677.85K915.92K32.94K92.07K135.99K15.29M-1.83M-245.51K-198.61K-1.99M547.10K8.39K241.69K-35.78K-64.19K287.81KN/AN/A900.00N/A2.19KN/AN/AN/A
Before Tax Income-22.29M-29.02M-20.02M-13.66M-7.64M-15.19M2.43M-18.81M-12.86M-6.22M-8.89M-1.89MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-2.00-677.00-613.41K-176.83K-264.03K135.99KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-22.29M-29.02M-19.41M-13.48M-7.38M-15.19M2.43M-18.81M-12.86M-6.22M-8.89M-1.89M-4.88M-6.03M-7.87M-13.13M-10.30M-61.35K-18.86K-18.08K-16.16K-15.59K-22.30K-36.52K-200.00
Interest ExpensesN/A-1.70MN/AN/AN/AN/A398.81K344.67K248.63K200.50K58.13KN/AN/AN/AN/A137.001.09M950.00N/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding26.78M24.55M23.09M15.57M3.71M2.94M2.32M1.86M1.59M1.17M1.05M84.40K74.66K64.34K50.93K48.25K33.88K1.51K1.51K1.51K1.51K1.51K1.51K1.38K1.00K
Diluted Shares Outstanding26.78M24.55M23.09M15.57M3.71M2.94M2.68M1.86M1.59M1.17M1.05M84.40K74.66K64.34K50.93K48.25K33.88K1.51K1.51K1.51K1.51K1.51K1.51K1.38K1.00K
EBITDA-23.01M-30.18M-21.31M-13.72M-7.83M-15.33M2.97M-18.34M-12.50M-5.97M-8.81M-1.89M-4.88M-6.28M-7.72M-13.29M-9.19M-60.40K-18.86K-19.88K-16.16K-15.59K-22.22K-36.32KN/A
EBITDA Margin-91.39%-1,184.21%-8,700.01%-4,423.18%-778.68%-917.04%111.55%-458.57%-226.51%-124.81%-1,750.06%-965.11%-360.08%0.00%0.00%0.00%-9,058.84%0.00%0.00%0.00%-739.79%-135.73%0.00%0.00%0.00%
EBIT-22.29M-30.72M-20.02M-13.66M-7.64M-15.06M2.83M-18.46M-12.61M-6.02M-8.83M-1.89M-4.88M-6.03M-7.87M-13.13M-9.21M-60.40K-18.86K-18.08K-16.16K-15.59K-22.30K-36.52K-200.00
EBIT Margin-88.52%-1,205.10%-8,175.86%-4,401.94%-760.36%-900.77%106.15%-461.71%-228.52%-125.68%-1,755.41%-968.31%-360.63%0.00%0.00%0.00%-9,085.45%0.00%0.00%0.00%-739.79%-135.73%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙